Dynamic purchasing system for pharmaceuticals
Original notice title
Système d'acquisition dynamique pour la fourniture de produits pharmaceutiques : médicaments et solutés versables
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Absence of estimated value and award criteria creates ambiguity in tender assessment.
As a DPS, many competitors may participate, increasing competition.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Dynamic Purchasing System (DPS)
- Supplies contract
- 3 lots
- Duration 109 MONTH
- Supply of pharmaceutical products (medicines and infusible solutions) across 8 lots covering therapeutic classes, injectable anticancer drugs, generic injectables, oral generics, parenteral nutrition, compassionate access products, and miscellaneous health products.
- Dynamic Acquisition System (DPS) allows continuous entry of candidates throughout its duration.
Show full summary
This is a Dynamic Acquisition System (DPS) for the supply of pharmaceutical products (medicines and infusible solutions) published by GCS Achats du Centre in France. It includes 8 lots covering various therapeutic categories. The DPS runs from 2025 to 2034, with a very long duration (109 months). No estimated value is provided. The procedure is restricted, and submission is electronic only in French. Selection criteria require DC1 and DC2 forms; award criteria are not specified. The DPS allows continuous entry of candidates until the end of the system.
Risks
Absence of estimated value and award criteria creates ambiguity in tender assessment.
As a DPS, many competitors may participate, increasing competition.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Restricted procedure: candidates must express interest and be selected to participate.
Administrative
- Electronic submission is mandatory.
- Tenders must be submitted in French.
Requirements may be incomplete.
Buyer
Name
GCS Achats du Centre
Location
Blois, FRA
Website
Buyer profile
Identifier
65455
Lots (8)
LOT-0001
Mise en concurrence au sein d'une classe thérapeutique
Competition within a therapeutic class
Duration
Category
Deadline
Award details
Show original TED data
Original TED description
Mise en concurrence au sein d'une classe thérapeutique
LOT-0002
Anticancéreux injectables
Injectable anticancer drugs
Duration
Category
Deadline
Award details
Show original TED data
Original TED description
Anticancéreux injectables
LOT-0003
Génériques injectables et autres voies, sauf formes sèches per os
Injectable generics and other routes, except dry oral forms
Duration
Category
Deadline
Award details
Show original TED data
Original TED description
Génériques injectables et autres voies, sauf formes sèches per os
LOT-0004
Génériques per os, formes sèches
Génériques per os, formes sèches
Duration
Category
Award details
LOT-0005
Génériques per os, formes sèches pour Préparation des Doses à Administrer Automatisée
Génériques per os, formes sèches pour Préparation des Doses à Administrer Automatisée
Duration
Category
Award details
LOT-0006
Nutrition parentérale
Nutrition parentérale
Duration
Category
Award details
LOT-0007
Autorisation d'Accès Compassionnel (AAC) avec ou sans classe ATC
Autorisation d'Accès Compassionnel (AAC) avec ou sans classe ATC
Duration
Category
Award details
LOT-0008
Divers - médicaments ou autres produits de santé
Divers - médicaments ou autres produits de santé
Duration
Category
Award details
Procurement Details
- Publication date
- 03 Feb 2025
- Notice type
- Contract notice — standard
- Languages
- French
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 75383-2025
- Source notice ID
- c0cf232e-ec90-4484-8315-a68da3554d29
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Absence of estimated value and award criteria creates ambiguity in tender assessment.
As a DPS, many competitors may participate, increasing competition.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications